Navigation Links
Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Date:1/3/2008

MONTVALE, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories Inc.'s KYTRIL(R) (granisetron hydrochloride) Tablets, 1mg (eq to 1 mg base). The Company received final approval following the expiration of Roche's patent on December 28, 2007, and plans to launch its product shortly.

KYTRIL (granisetron hydrochloride) Tablets, 1 mg (eq to 1 mg base) is indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin; and, nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. The product had annual sales of approximately $88 million for the twelve months ended October 2007, based on IMS sales data.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 25 proprietary products in the U.S. and more than 550 products globally outside of the U.S.

Forward-Looking Statements

Except for the historical information contained herein, the statements made in this press release constitute
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Three years ago, Dr. Jeffrey Gosin announced ... Vascular & Vein Center! Dr. Gosin’s center is ... is his mission to provide the highest quality care in ... Dr. Jeffrey Gosin is Board Certified in Surgery and Vascular ... and Jefferson Medical College. He completed a General Surgery residency ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dr. ... announced an exclusive deal to patients looking to undergo ... 1 through 30, patients will be able to get ... procedure, for just $600. For a three-treatment package, which ... treatment at no cost. , Dr. Juanita Jenyons, M.D., ...
(Date:5/28/2015)... New Jersey Plastic Surgeon and “NJ Top ... With over 30 years of experience in the ... Dr. Rafizadeh knows what it takes to achieve that ... involves the principles of proportion, harmony and balance. ... comfort and personalized care from the moment a patient ...
(Date:5/28/2015)... Lanham, Md. (PRWEB) May 28, 2015 ... Weekend Sweepstakes grand prize winner Robert Davis of Newark, ... Davis to congratulate him on winning the $10,000 sweepstakes ... winners from over 100,000 entries from around the country ... prize. The drawing took place on May 21 at ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Are policies ... after a hospital stay triggering financial pain for seniors? ... American Journal of Managed Care set to figure out, ... recent federal rule change. , The study, “Observation Encounters ... A. Vashi, MD, MPH, examined how Medicare policies that ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3
... DURHAM, N.C. -- A combination of two drugs shows promise ... originates in the eye and spreads to other organs, according ... Center researchers. , The drugs -- decitabine, which can ... an immune system protein -- may work together to cause ...
... laboratory of Dr. David R. Soll at the University ... field of cancer research, thanks to a new agreement ... part of the National Institutes of Health. , The ... for Cancer ( http://proteomics.cancer.gov ) recently selected the Developmental ...
... N.Y. (Tues., Sept. 4, 2007) Skin cancer is ... States, according to the Centers for Disease Control. But ... scientists must use model organisms, such as mice, to study ... Cold Spring Harbor Protocols ( www.cshprotocols.org ) includes ...
... in heart muscle, researchers say , , TUESDAY, Sept. 4 ... treatment in women who have angina, the piercing chest ... with heart disease, has been given fast-track status by ... will enroll about 300 women at 50 medical centers ...
... for stroke patients whove lose part of their vision? ... & Neural Repair explores that question. , The researchers ... the training would induce specific changes in the brains ... never in humans with brain injury. The home-based therapy ...
... 4 EaglePicher Corporation,(EaglePicher) today announced that it ... Boron, LLC (EP Boron) to,Ceradyne, Inc. (Nasdaq: ... Oklahoma, has produced enriched boron,isotopes and products containing ... materials industries. Its products include,isotope B11, an additive ...
Cached Medicine News:Health News:Promising drug combination may help those with ocular melanoma that has spread 2Health News:Laboratory at UI plays major role in diagnosing cancer 2Health News:Laboratory at UI plays major role in diagnosing cancer 3Health News:A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols 2Health News:Trial to Test Gene Therapy for Angina in Women 2Health News:Trial to Test Gene Therapy for Angina in Women 3Health News:EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million 2
(Date:5/28/2015)... , May 28, 2015  Transportation Insight, ... announces winning the SDCE100 Award for the ... Demand Chain Executive magazine. Transportation Insight ... goods distributor quantify and control supply chain ... highly competitive market. Deploying Transportation Insight,s Enterprise ...
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015 /PRNewswire/ ... investigating whether certain officers and directors ... duties to shareholders.  Eleven Biotherapeutics is a clinical-stage ... development of protein therapeutics to treat eye diseases, ... .   View this press release ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... treatment is to match the right drug ... cases, even to design the appropriate treatment ...
Breaking Medicine Technology:Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 2Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 3Transportation Insight Wins SDCE100 Award for Delivering End-to-End Supply Chain Value 4Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Findings Show Survival Improvement with Lower Doses ... and other,Drugs in Newly Diagnosed Myeloma -, ... -- The,International Myeloma Foundation (IMF) - supporting ... myeloma patients,families, researchers and physicians - today ...
... April 5, 2007-- Stent thrombosis,restenosis and lifelong prescriptions. ... used as part of their heart,operations may be ... than medical experts have ever publicly acknowledged. Recent,articles ... drug-eluting stents continue to take blood thinners, they,could ...
Cached Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2
...
... Storage in bottom of tray ... etc. Anodized aluminum. Durable and ... rust. Security locks ensure against ... bumper guards hold instruments in ...
Lance shaped gently curved tip. Flat serrated handle with polished finish....
For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model....
Medicine Products: